logo

NOVARTIS A(NYSE:NVS)
Novartis AG is committed to improving health and well-being through innovative products and services. The company aspires to capture and hold a leadership position in all of their businesses with a strong, sustainable performance based on continuous innovation. Their long-term success is founded on meeting the expectations of all our stakeholders - their customers, their people, their shareholders and the communities in which they live and work.
# Employees: 98200
Address: Lichtstrasse 35 4056,Basel,,CHE
Phone: 877 999-8850
Fax: 41 61 324 84 44
Website:
Email: investor.relations@group.novartis.com
Sector: Medical
Industry: MED-DRUGS
Executive Officers
Daniel Vasella (Chairman)
Helmut Sihler (Vice Chairman)
Hans- J??rg Rudloff (Vice Chairman)
h.c. Birgit Breuel (Dir.)
Pierre Landolt (Dir.,)
Dividend
Ex-Dividend Date: 1/1/1990
Annual Dividend: $1.45
Current Dividend Yield: $2.74
Dividend Paid (3 months): $0.00
Indicated Dividend: $0.44
Earnings
Last Earnings Date: 9/30/2009
Next Earnings Date(Expected): 1/27/2010
Mean EPS (Next Qtr): $0.97
Mean EPS (Year): $3.63
Mean Estimate(Long Term): $1.89
P/E Ratio(Based on EPS estimate): 14.630
Number of Estimates: 7
Shares Performance
Period NVS Compare to S&P
YTD 6.77 % -11.63 %
4 Weeks 2.39 % 1.28 %
12 Weeks 14.48 % 7.93 %
Shares Information
Analyst Coverage: Y
Avg Volume: 1209546
Shares Outstanding: 2271M
Market Cap: $120.67B
52 Week High: $54.04
52 Week Low: $33.96
P/E Ratio: 15.910
PEG Ratio: 7.740
Split: On 5/11/2000 NVS split by factor of 2.000
Earnings Performance
EPS Growth in Last Quarter: 3.37 %
EPS Growth in Last Year: 0.00 %
Sales Growth in Last Quarter: 3.20 %
Sales Growth in Last Quarter: 3.15 %
Financials
Qtr Book Value: $2.26
Cash Flow/Share: $14.74
Change in Payout Ratio: 0.140
Price/Sales: 2.900
Fundamental data is provided by Zacks Investment Research, market data is provided by AlphaTrade. , and Commentary and Press Releases provided by Quotemedia